Bladder cancer organoids as a functional system to model different disease stages and therapy response

Bladder Cancer (BLCa) inter-patient heterogeneity is the primary cause of treatment failure, suggesting that patients could benefit from a more personalized treatment approach. Patient-derived organoids (PDOs) have been successfully used as a functional model for predicting drug response in differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Minoli, Martina, Cantore, Thomas, Hanhart, Daniel, Kiener, Mirjam, Fedrizzi, Tarcisio, La Manna, Federico, Karkampouna, Sofia, Chouvardas, Panagiotis, Genitsch, Vera, Rodriguez-Calero, Antonio, Compérat, Eva, Klima, Irena, Gasperini, Paola, Kiss, Bernhard, Seiler, Roland, Demichelis, Francesca, Thalmann, George N., Kruithof-de Julio, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113240/
https://www.ncbi.nlm.nih.gov/pubmed/37072390
http://dx.doi.org/10.1038/s41467-023-37696-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113240/
https://www.ncbi.nlm.nih.gov/pubmed/37072390
http://dx.doi.org/10.1038/s41467-023-37696-2

Ejemplares similares